McDonald Charles Ian, Fraser John Francis, Coombes Jeff S, Fung Yoke Lin
Critical Care Research Group, The Prince Charles Hospital and The University of Queensland, Brisbane, QLD, Australia
Critical Care Research Group, The Prince Charles Hospital and The University of Queensland, Brisbane, QLD, Australia.
Eur J Cardiothorac Surg. 2014 Dec;46(6):937-43. doi: 10.1093/ejcts/ezt637. Epub 2014 Jan 30.
There is an increased oxidative stress response in patients having cardiac surgery, haemodialysis or extracorporeal membrane oxygenation that is related to poorer outcomes and increased mortality. Exposure of the patients' blood to the artificial surfaces of these extracorporeal devices, coupled with inflammatory responses, hyperoxia and the pathophysiological aspects of the underlying illness itself, all contribute to this oxidative stress response. Oxidative stress occurs when there is a disruption of redox signalling and loss of control of redox balance. Ongoing oxidative stress occurring during extracorporeal circulation (ECC) results in damage to lipids, proteins and DNA and contributes to morbidity and mortality. This review discusses reactive species generation and the potential clinical consequences of oxidative stress during ECC as well as provides an overview of some current antioxidant compounds that are available to potentially mitigate the oxidative stress response.
接受心脏手术、血液透析或体外膜肺氧合的患者会出现氧化应激反应增强的情况,这与较差的预后和死亡率增加有关。患者的血液暴露于这些体外设备的人工表面,再加上炎症反应、高氧状态以及潜在疾病本身的病理生理因素,都导致了这种氧化应激反应。当氧化还原信号传导中断且氧化还原平衡失去控制时,就会发生氧化应激。体外循环(ECC)期间持续的氧化应激会导致脂质、蛋白质和DNA受损,并导致发病率和死亡率上升。本文综述了ECC期间活性物质的产生以及氧化应激的潜在临床后果,并概述了一些目前可用于潜在减轻氧化应激反应的抗氧化化合物。